Lisa Schnirring | News Editor | CIDRAP NewsJun 30, 2020Also, the Recovery trial announces that a review showed no COVID benefit for a well-known HIV treatment.
EU travel list excludes US, other COVID-19 hot spots
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Teen vaccination cut COVID-19 cases by 37% in California, new data show
- US study shows post-COVID rebound in inappropriate antibiotic prescribing
- Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
- National COVID-19 guidelines vary widely, often promote ineffective treatments